|
|
 |
|
|
<< Back
Limited Competition for Research Centers in Minority Institutions Infrastructure for Clinical and Translational Research (RCTR) [U54]
|
|
Description
|
Grant Amounts: Unspecified.
The purpose of this initiative is to support the development of infrastructure required for the conduct of clinical and translational research in institutions funded via the Research Centers in Minority Institutions (RCMI) Program. The RCMI Infrastructure for Clinical and Translational Research (RCTR) represents a re-organization of the existing RCMI programmatic activities in support of clinical and translational research. These programs include the RCMI Clinical Research Infrastructure Initiative (RCRII) P20 Awards; Centers of Clinical Research Excellence (CCRE) U54 Awards; and Comprehensive Centers on Health Disparities (CCHD) U54 Awards. This re-organization also presents an opportunity to enhance research training and career development efforts across the institutions and enhance synergy with the Clinical Research Education and Career Development (CRECD) R25 awards and/or other institutional training programs. The re-organization will effect improved coordination and synergy between the clinical and translational research and research training activities at grantee institutions. In addition, using a single award mechanism will allow all of the clinical and translational research activities to be coordinated within a single administrative infrastructure.
The RCTR will better position institutions for conducting clinical and translational research, especially research that is focused on health disparities, and for competing for clinical and translational research funding by:
facilitating the development of each awardee institution’s clinical and translational research capacity;
facilitating intra-institutional and inter-institutional collaborations and partnerships;
developing synergy between clinical and translational research training and career development activities in CRECD awards, Clinical and Translational Science Awards, and other NIH training awards; and
facilitating participation in the RCMI Translational Research Network consortium.
The RCTR must provide infrastructure to:
(1) Study the underlying causes of diseases, including those diseases that disproportionately affect the U.S. minority populations;
(2) Develop approaches for the prevention, diagnosis and/or treatment of diseases to improve health and reduce health disparities;
(3) Integrate basic, clinical and translational research by fostering collaboration among disciplines, departments and/or schools of an institution, and collaboration with investigators across institutions; and
(4) Facilitate mentored clinical and translational research training and provide career development activities in clinical and translational science.
Examples of health disparities among members of racial and ethnic minority populations include: Cancer Screening and Management, Diabetes, HIV/AIDS, Infant Mortality, Mental Health, Hepatitis, Syphilis, Tuberculosis, and Chronic Kidney Diseases. |
|
|
|
|
Funding Organization
|
US Department of Health and Human Services
Public Health Service
National Institutes of Health
National Center for Research Resources
|
|
|
|
|
|
|
|
|
|
Eligible Organizations
|
Consortia
Research Institutions
Unrestricted
|
|
|
|
Award Amount Notes
|
Current RCMI Clinical Research Infrastructure Initiative P20 Awards and U54 Cooperative Agreements to establish Centers of Clinical Research Excellence, or Cooperative Agreements to establish Comprehensive Centers on Health Disparities held by successful applicants will transition into the RCTR.
Applicants must re-budget the funds from current awards to accomplish the goals of the RCTR application. In developing the budget, applicants may request the direct costs of current P20 and U54 awards plus up to an additional $1 million dollars. Total costs per year should not exceed $4.2 million (including F&A costs).
Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. Although the financial plans of the IC(s) provide support for this program, awards pursuant to this funding opportunity are contingent upon the availability of funds.
|
|
|
|
|
|
|
|
|
Application Contact
|
Amy McGuire
Office of Grants Management
NCRR
6701 Democracy Blvd., Room 1052
Bethesda, MD 20892
Phone: (301) 435-0853
|
|
|
|
Technical Contact
|
Regine Douthard
Div of Rsch InfrastructureNCRR
6701 Democracy Blvd., Room 932
Bethesda, MD 20892
Phone: (301) 435-1759
|
|
|
|
|
|
Subjects
|
Clinical Research
Hepatitis
HIV/AIDS Prevention
Syphilis
TB
|
|
|
|
|
|
|
|
Application Process
|
The PHS 398 application instructions are available at http://grants.nih.gov/grants/funding/phs398/phs398.html in an interactive format. For further assistance contact GrantsInfo, Telephone (301) 435-0714, Email: GrantsInfo@nih.gov.
Telecommunications for the hearing impaired: TTY 301-451-5936.
Applications must be prepared using the most current PHS 398 research grant application instructions and forms. Applications must have a D&B Data Universal Numbering System (DUNS) number as the universal identifier when applying for Federal grants or cooperative agreements. The D&B number can be obtained by calling (866) 705-5711 or through the web site at http://www.dnb.com/us/. The D&B number should be entered on line 11 of the face page of the PHS 398 form.
The title and number of this funding opportunity must be typed in item (box) 2 only of the face page of the application form and the YES box must be checked.
|
|
|
|
|
|
|
|
|
Disclaimer: NPIN provides this information as a public service only. The views and information provided about the materials, news, funding opportunities, organizations, and conferences do not necessarily state or reflect those of the U.S. Department of Health and Human Services, CDC, or NPIN.
|
|
|
cdcnpin.org Fund Record #3905
|
|
<< Back
|
|
|
|
